Additionally, it can exert anti-angiogenic effects by regulating VEGF, VEGFR, and HIF1A in breast cancer (Wang et al., 2012, 2017a, 2017b; Zhao et al., 2013). This evidence concerns the gene HIF1A and breast carcinoma.